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Preeclampsia (PE) and its complications have become the leading cause of maternal
and fetal morbidity and mortality in the world. And the development of PE is still barely
predictable and thus challenging to prevent and manage clinically. Oxidative stress
contributes to the development of the disease. Our previous study demonstrated that
exogenous Alpha-1 antitrypsin (AAT) played a cytoprotective role in vascular endothelial
cell by suppressing oxidative stress. In this study, we aim to investigate whether AAT
contributes to the development of PE, and to identify the mechanism behind these
effects. We found that AAT levels were significantly decreased in placenta tissues from
women with PE compared that of healthy women. Notably, we demonstrate that AAT
injection is able to relieve the high blood pressure and reduce urine protein levels in a
dose-dependent manner in PE mice. In addition, our results showed that AAT injection
exhibited an anti-oxidative stress role by significantly reducing PE mediated-upregulation
of ROS, MMP9 and MDA, and increasing the levels of SOD, eNOS, and GPx with
increased dosage of AAT. Furthermore, we found that AAT injection inactivated PE
mediated activation of PAK/STAT1/p38 signaling. These findings were confirmed in
human samples. In conclusion, our study suggests that exogenous AAT injection
increases the antioxidants and suppresses oxidative stress, and subsequent prevention
of PE development through inactivation of STAT1/p38 signaling. Thus, AAT would
become a potential strategy for PE therapy.
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INTRODUCTION
Preeclampsia (PE) and its complications have become the leading cause of maternal and fetal
morbidity and mortality in the world, accounting for nearly 40% of births delivered at early
gestation (Sanchez-Aranguren et al., 2014). About 5–10% of all pregnant womenworldwide present
PE, and the development of PE is still barely predictable and thus challenging to prevent and
manage clinically (Cindrova-Davies, 2014). PE is characterized by hypertension, proteinuria, and
edema. Although the pathophysiology of preeclampsia remains undefined, it is accepted that early
in pregnancy, PE is initiated by inadequate trophoblast invasion, which produces an increase in
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oxidative stress contributing to the development of the disease in
the later phases (Hansson et al., 2014).
Oxidative stress of the placenta is a key risk factor by
resulting in endothelial dysfunction via direct actions on
the vasculature (Sanchez-Aranguren et al., 2014). Several
important antioxidants, such as superoxide dismutase
(SOD) and glutathione peroxidase (GPx) that protects the
vasculature from ROS and maintains the vascular function, are
significantly decreased in the maternal circulation of women
with preeclampsia (Dordevic et al., 2008). Reduced SOD activity
also has been reported in placentas of women with preeclampsia,
suggesting that the total antioxidant protective capacity was
decreased in women with preeclampsia (Zhang et al., 2008).
Decreased levels of antioxidant vitamins C, A, E, and glutathione
levels were also observed in the maternal circulation of women
with preeclampsia (Cindrova-Davies, 2014). And administration
of vitamins C and E can block hypoxia-reoxygenation (HR)-
mediated sFlt-1 secretion, via inhibition of p38 and NF-κB
signaling pathways (Cindrova-Davies et al., 2007; Cindrova-
Davies, 2009). Thus, antioxidant treatment may be a potential
strategy for preeclampsia therapy.
Alpha-1 antitrypsin (AAT), a serine protease inhibitor, is
one of the most abundant proteins in human peripheral serum,
which is primarily produced by the liver, lungs, and human
amniotic epithelial cells (Zsila, 2010). AAT can neutralize
elastase that is required for neutrophil migration and for
tissue remodeling (Al-Omari et al., 2011). Adequate inhibitory
activity of AAT is critical for the prevention of proteolytic
tissue damage and anti-inflammation (Catarino et al., 2012).
It was reported that AAT levels was significantly increased
during the third trimester of pregnancy. However, AAT
levels were lower in the women with preeclampsia than the
healthy women and correlated with protease inhibitory capacity
(Twina et al., 2012). Cindrova-Davies et al. demonstrated
that oxidative stress induced by HR could activate the p38
and stress-activated protein kinase mitogen-activated protein
kinase (MAPK) pathways as well as nuclear factor-κB pathway,
which mediated the release of proinflammatory factors involved
in development of PE (Cindrova-Davies et al., 2007). Our
previous study have demonstrated that exogenous AAT alleviated
hypoxia/reoxygenation injury in a dose- and time- dependent
manner, and overexpression of AAT inactivated PAK/p38
signaling and suppressed oxidative stress, indicating that AAT
played a cytoprotective role in vascular endothelial cell (Feng
et al., 2015). In this study, we aim to investigate whether AAT
injection contributes to the improvement of PE, and to identify
the mechanism behind these effects.
MATERIALS AND METHODS
Human Placenta Tissues and Blood
Samples
This study was approved by Ethics Committees of Nanjing
Medical University and the Wuxi Maternal and Child Health
Hospital Affiliated to Nanjing Medical University. Written
informed consent was obtained from all women. PE was
defined as blood pressure ≥140/90mmHg at least in two
occasions, and proteinuria at least 300 mg/day on or after
20 weeks of gestation. Placenta tissue samples were obtained
from 209 women postpartum: 120 normotensive pregnant
and 89 preeclamptic. And blood samples were obtained from
these women in 24th to 34th gestational weeks. The clinical
characteristics of normotensive women and preeclamptic women
were shown in Table 1. The placenta volume and weight of
newborn from preeclamptic women was lower than that from
normotensive women (Table 1).
PE Model Preparation
Institute of Cancer Research (ICR) mice were obtained from
Hunan SJA Co. (Changsha, China). The experimental animals in
this study were approved by the Institutional Animal Care and
Research Advisory Committee of Nanjing Medical University.
The female mice were randomly divided into normal pregnant
group (n = 8) and PE model group (n = 32). The mice were
raised with the female-male ratio of 1:1 in the same rearing
cage for mating. The time after the morning of the observation
of the vaginal plug was designated as post-coital day 0.5. The
PE model was prepared as previously described (Omatsu et al.,
2005). Briefly, phosphatidylserine/dioleoyl-phosphatidycholine
(PS/PC) (Sigma-Aldrich, St. Louis, MO, USA) was prepared by
mixing 80% dioleoyl-PC and 20% PS with a final concentration of
10mg/ml. One hundred microliters (1mg) of PS/PC suspension
(PE group, 32 animals) and 100µl of saline as a control (normal
group, eight animals) were injected into tail veins every day
from days 5.5 to 16.5 of pregnancy. In PE group, the mice were
randomly divided into four groups each for eight animals: PE+
saline, PE+ AAT 25, PE+ AAT 50, and PE+ AAT 75. AAT
solution (25, 50, or 75mg/kg) and 100µl of saline as a control
were injected into tail veins every day from days 0.5 to 16.5 of
pregnancy.
Blood Pressure, Urinary Protein, and
Placenta Collection
Non-invasive rat tail blood pressure detecting method was used
to measure blood pressure after the behavior and heart rate had
stabilized on days 0.5, 14.5, and 16.5. The measurement was
repeated at least three times. The proteinuria was measured on
day 17.5. On day 17.5 of pregnancy, the animals were euthanized
TABLE 1 | Clinical characteristics of normotensive and preeclamptic
women.
Variables Normotensive Preeclamptic t-test
(n= 120) (n = 89) P
Age 28.78± 0.48 30.62±0.64 0.85
Placenta volume (cm3) 61.54± 2.61 56.62±2.15 0.015
Crown-lump length (cm) 6.14± 0.09 6.06±0.11 0.99
Placenta quotient# 9.96± 0.29 9.13±0.38 0.083
Week of gestation (week) 39.66± 0.09 38.92±0.18 0.001
Weight of newborn (g) 3419± 35.97 3286±53.76 0.034
#Placenta quotient, Placenta volume/Crown-lump length.
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under the anesthesia by overdose chloral hydrate. The peripheral
blood was collected for further analysis. The animals were
dissected, and the fetuses were obtained to evaluate the weights
and placentas were collected for western blot and IHC analysis.
Reagents
Primary antibodies: rabbit monoclonal anti-alpha 1 antitrypsin
(cat no. ab179443), rabbit monoclonal anti-PAK1 (cat no.
ab40852), rabbit monoclonal anti-PAK1 (phospho S199; cat no.
ab192814), rabbit monoclonal anti-PAK1 (phospho T212; cat
no. ab75599), rabbit polyclonal anti-STAT1 (cat no. ab2415),
mouse monoclonal anti- STAT1 (phospho Y701; cat no.
ab29045), rabbit monoclonal anti- STAT1 (phospho S727; cat
no. ab109461), rabbit polyclonal anti-p38 (cat no. ab7952), and
rabbit monoclonal anti-p38 (phospho T180 + Y182; cat no.
ab195049) fromAbcam (Cambridge, UK); rabbit polyclonal anti-
p38 (phospho Tyr322; cat no. AP50174) fromAbgent (San Diego,
CA, USA); mouse monoclonal anti-GAPDH (cat no. SC-365062)
were from Santa Cruze (Dallas, Texas, USA). Horseradish
peroxidase-conjugated secondary goat anti-mouse and goat anti-
rabbit antibodies were from Boster (Wuhan, China). HRP-
polymer anti-mouse IHC kit and HRP-polymer anti-rabbit IHC
kit were from Maixin (Fuzhou, China). ELISA Kit for Alpha-
1-Antitrypsin (AAT), ELISA Kit for Nitric Oxide Synthase 3,
Endothelial (eNOS), ELISA Kit for Matrix Metalloproteinase 9
(MMP9), and ELISA Kit for soluble fms-like tyrosine kinase-
1 (sFlt-1) were from Cloud-Clone Corp. (Houston, TX, USA);
superoxide dismutase (SOD) activity assay kit and glutathione
peroxidase (GPx) activity assay kit were from Biovision (Milpitas,
California, USA); lipid peroxidation malondialdehyde (MDA)
assay kit and reactive oxygen species (ROS) assay kit were from
Beyotime (Shanghai, China).
Immunohistochemical (IHC) Staining
The placenta tissues were embedded in paraffin and cut into
4µm slides. The slides were deparaffinized in dimethylbenzene
and hydrated in alcohol gradient. After inactivating endogenous
peroxidase in 3% hydrogen peroxide, slides were then retrieved
in citric acid buffer (pH6.0) by microwave for 15min. Slices
were blocked by normal goat serum, and incubated with primary
antibody overnight at 4◦C. The slides were then washed with
TBST and incubated with appropriate secondary antibody for 2 h
at 37◦C. The sections were then washed with TBST and stained
by using DAB Detection Kit (Solarbio, Beijing, China). Finally,
the sections were counterstained with hematoxylin.
Western Blot Analysis
RIPA lysis buffer was used to extract protein from indicated cells.
BCA Protein Assay Kit (Thermo Scientific, USA) was used to
measure the protein concentration. Total 60µg of protein were
separated on 10% SDS-PAGE gels and blotted onto nitrocellulose
membranes. The membranes were blocked for 2 h with 5% non-
fat dry milk diluted with tris buffered saline (TBS) and incubated
with primary antibodies overnight at 4◦C. The membranes
were washed with TBST, and then incubated with appropriate
horseradish peroxidase-conjugated secondary antibody for 1 h at
37◦C. Enhanced chemiluminescence reagent (Merck Millipore,
Germany) was used to detect the signal on the membrane.
The expression of genes was analyzed by normalizing to the
expression of the internal control (GAPDH).
ELISA
ELISA kits were used to detect the levels of AAT, eNOS, MMP9,
s-Flt, ROS, MDA, SOD, and GPx in the serum according to
manufacturer’s instructions.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism 5
software (Graphpad Software, Inc., La Jolla, CA, USA) and
the data are presented as the mean ± standard deviation. An
unpaired two tailed Student’s t-test or one way analysis of
variance (ANOVA) with Bonferroni t post-test was used to
analyze the data depending on conditions. P < 0.05 was
considered to indicate a statistically significant difference.
RESULTS
AAT Contributes to the Development of
Preeclampsia
We established PE animal model by injecting ps/pc into pregnant
mice. As shown in Figure 1, the results showed that ps/pc
injection significantly increased blood pressure on day 14.5,
decreased the fetal weight and elevated the urine protein levels
compared with the normal group, indicating that the PE model
was successfully established. To investigate the role of AAT on
PE, we injected a range of AAT solution (25, 50, or 75mg/kg) into
tail veins every day from days 0.5 to 16.5 of pregnancy in PEmice,
and 100µl of saline injection was used as a control. We found
that AAT injection significantly relieved the high blood pressure,
increased the fetal weight and reduced urine protein levels in
a dose-dependent manner (Figure 1). Notably, we found that
the concentration of AAT in peripheral serum was significantly
lower in PE mice than normal mice (Figure 2A). Furthermore,
we gradually increased concentration of AAT in peripheral
serum (Figure 2A) and then analyzed some biomarkers of PE in
peripheral serum. We observed the fact that the concentrations
of eNOS, MMP9, and s-Flt in serum were significantly increased
in PE mice (Figures 2B–D). As expected, the concentrations of
eNOS, MMP9, and s-Flt in serum were reduced with increased
dosage of AAT (Figures 2B–D). Thus, these results suggest that
AAT injection is able to relieve the symptoms of PE mediated by
ps/pc.
AAT Suppresses Oxidative Stress Induced
by PE
Oxidative stress is an important risk factor for PE. We next
investigate whether AAT can suppress oxidative stress to improve
PE. We analyzed the oxidative stress related factors, including
ROS, lipid peroxidation malondialdehyde (MDA), SOD, and
glutathione peroxidase (GPx), in peripheral serum. Our results
showed that AAT injection significantly reduced PE mediated-
upregulation of ROS andMDA, while increased the levels of SOD
and GPx with increased dosage of AAT (Figure 3).
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FIGURE 1 | AAT decreases blood pressure and urinary protein levels, and increases fetal weights in PE animal model. (A) Non-invasive rat tail blood
pressure detecting method was used to measure blood pressure on days 0.5, 14.5, and 16.5; the measurement was repeated at least three times. (B) The fetuses
were obtained to evaluate the weights; (C) The proteinuria was measured on day 17.5 of pregnancy. N = 8. **p < 0.01, ***p < 0.001.
FIGURE 2 | AAT decreases the concentration of eNOS, MMP9, and s-Flt in blood from PE animals. ELISA was used to detect the concentration of AAT (A),
eNOS (B), MMP9 (C), and s-Flt (D) in serum from PE or normal animals after indicated treatment. N = 8. *p < 0.05, **p < 0.01, ***p < 0.001.
AAT Inactivates PAK/STAT1/p38 Signaling
In addition, we obtained the placenta tissues from the pregnant
mice to analyze oxidative stress related downstream molecules.
We found that PE activated the PAK/STAT1/p38 signaling
that enhanced the phosphorylation levels of these genes. We
demonstrated that AAT was able to reduced the phosphorylation
levels of PAK1 at both of S199 and T212 sites, whereas decreased
the phosphorylation levels of STAT1 and p38 at Y701 and
T180/Y182, respectively, but not alter the phosphorylation levels
of STAT1 and p38 at S727 and Tyr322 (Figure 4). Furthermore,
we performed IHC assay to confirm that upregulation of AAT
was observed in placenta tissues and the phosphorylation levels
of p38 at T180/Y182 was also significantly decreased by AAT
injection in placenta tissues (Figure 5).
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FIGURE 3 | AAT decreases the activity of ROS and the concentration of MDA, whereas increases the activity of SOD and GPx. ELISA was used to detect
the actvity of ROS (A), the concentration of MDA (B), and the activity of SOD (C), and GPx (D) in serum from all groups. N = 8. *p < 0.05, **p < 0.01, ***p < 0.001.
AAT Levels Are Lower in Human Placenta
Tissues of PE Patients than That of Health
People
To further confirm our results in animals, we collected 120
placenta samples from health people and 89 placenta samples
from PE patients to perform IHC to analyze the expression of
AAT. Clinically, our data reveal that AAT levels were lower in
placenta tissues of PE patients than that of in health people
(Figures 6A,B). In addition, we also detected the concentration
of AAT in blood from the health people and PE patients using
ELISA. In line with the results shown in IHC, the concentration
of AAT (1.08 ± 0.08 ng/ml) in blood from PE patients was
significantly decreased compared with the health people (1.9
± 0.18 ng/ml; Figure 6C). Furthermore, we analyzed the key
molecules in PAK/STAT1/p38 signaling in human placenta
samples using western blot. We found that the expression
levels of p-PAK1(S199), p-STAT1(Y701), and p-p38(T180/Y182)
was significantly increased in placenta tissues of PE patients
compared with that of in health people (Figures 6D,E).
DISCUSSION
In this study, we find that AAT levels are significantly decreased
in placenta tissues fromwomenwith PE compared that of healthy
women. Notably, we demonstrate that AAT injection is able to
relieve the high blood pressure and reduce urine protein levels in
a dose-dependent manner, and thus improve PE.
AAT is a typical serine protease inhibitor with potent anti-
neutrophil protease activities, such as against elastase and
proteinases, which plays an important role in controlling tissue
damage by proteases in the microenvironment of inflammation
(Bironaite et al., 2001). Significant decreases in serum levels
of human AAT have been associated with the development
of emphysema. The decreased levels or activity of AAT are
attributed in part to excessive polymerization of the mutant
protein and to post-translational changes induced by oxidative
stress. And AAT levels were lower in the woman with
preeclampsia than the healthy woman (Twina et al., 2012). It
seems conceivable that polymerized serine protease inhibitor
may occur in hepatocytes (Mahadeva et al., 1999), contributing
to low levels of circulating AAT in woman with preeclampsia.
AAT also exhibits a procellular survival effect in models of
serum deprivation and ischemia-reperfusion injury in vascular
endothelial cells and in alveolar endothelial cells via direct
caspase-3 inhibition (Petrache et al., 2006). Smoking can enhance
oxidative stress. Increased lipid peroxide and nitric oxide end
products, and decreased superoxide dismutase (SOD) activity
and serum AAT were observed in cigarette smokers, and further
increase in number of cigarettes per day exacerbates the oxidative
stress with decrease in AAT (Sayyed et al., 2008; Wada et al.,
2012), which may serve as a marker of oxidative stress (Ueda
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FIGURE 4 | AAT inactivates PAK/STAT1/p38 signaling that enhanced by PE. Western blot analysis for PAK, phosphorylated PAK, STAT1, phosphorylated
STAT1, p38 and phosphorylated p38 in mice placenta. N = 3. *p < 0.05, **p < 0.01, ***p < 0.001.
et al., 2002). Children with alpha-1 antitrypsin deficiency showed
increased oxidative stress in the serum and have significantly
lower total glutathione and reduced glutathione levels leading
to an accumulation of hydrogen peroxide that would explain
the significantly increased levels of oxidative stress biomarkers
observed in these patients (Escribano et al., 2015). Our results
showed that AAT injection exhibited an anti-oxidative stress
role by significantly reducing PE mediated-upregulation of ROS
and MDA, and increasing the levels of SOD and GPx with
increased dosage of AAT. In addition, AAT injection also
increased the expression of endothelial nitric oxide synthase
(eNOS) but decreased the expression of matrix metalloproteinase
9 (MMP9), a useful biomarker of susceptibility to severe PE
and its early onset related to insufficient invasion of trophoblast
leading to superficial and unsuccessful placentation (Shokry
et al., 2009; Wang et al., 2010). Lockwood CJ showed that
tumor necrosis factor-α (TNF-α) significantly enhanced MMP-
9 mRNA and protein levels and activity, suggesting that excess
macrophage-derived TNF-α augmented expression of MMP-9
in decidual cells to interfere with normal stepwise extravillous
trophoblast invasion of the decidua. They also showed that
p38 mitogen-activated protein kinase signaling mediated TNF-α
enhancement of MMP-9(Lockwood et al., 2014). Thus, activation
of p38 signaling might indirectly regulate MM9 expression and
activity via increasing the release of proinflammatory cytokines.
Increased circulating levels of anti-angiogenic factors, such as
soluble fms-related tyrosine kinase-1 (sFlt-1), were observed
in PE (Cindrova-Davies, 2014). And it was reported that p38
inhibition provides protective effects in H/R-exposed human
umbilical vein endothelial cells (HUVECs) by suppressing
oxidative stress, inhibiting apoptosis, and promoting their
potential for in vitro angiogenesis; H/R intervention causes the
induction of Gadd45α leading to p38 activation and ultimately an
increase in sFlt-1 secretion in HUVECs (Luo et al., 2011). These
studied indicate that the anti-angiogenic factors, such as soluble
fms-related tyrosine kinase-1 (sFlt-1), as well as proinflammatory
cytokines, such as TNF-α and IL-1β, may be the potential
downstream effectors of PAK/STAT1/p38 signaling pathway in
PE. Nitric oxide (NO), one of the major endothelium-derived
vasoactive mediators, is synthesized by endothelial NO synthases
(eNOS). An increased eNOS expression and hence increased
NO production may be an adaptive response to the increased
resistance and poor perfusion in the pathological pregnancies
(Myatt et al., 1997). SOD is an antioxidant enzyme highly specific
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FIGURE 5 | AAT decreases the expression of phosphorylated p38 (T180/Y182) in placenta from PE mice. Representative images of IHC staining for
AAT. AAT expression was decreased in placenta from PE mice, and significantly increased after AAT injection (upper); Representative images of IHC staining
for phosphorylated p38 (T180/Y182). p-p38 (T180/Y182) expression was enhanced in placenta from PE mice, and significantly decreased after AAT injection
(lower). Bar = 50µm. N = 8.
FIGURE 6 | The expression of AAT was dramatically decreased in blood and placenta tissues from PE patients. (A) Representative images of IHC staining
for AAT. Bar = 50µm. (B) AAT expression was decreased in placenta from PE patients. (C) ELISA was used to detect the concentration of AAT in blood from PE
patients. (D) Western blot analysis for PAK, phosphorylated PAK, STAT1, phosphorylated STAT1, p38 and phosphorylated p38 in human placenta. (E) Quantification
of the band in (C). *p < 0.05, **p < 0.01, ***p < 0.001.
for superoxide elimination. An increased oxidative level and
decreased antioxidant activities in the peripheral blood of women
with preeclampsia have been reported (Suhail et al., 2009),
suggesting that oxidative stress markers play a significant role
in the pathophysiology of pre-eclampsia (Sharma et al., 2006).
Inadequate amount of antioxidant enzymes in circulation may
be important contributing factor associated with oxidative stress
leading to endothelial dysfunction in mothers with preeclampsia
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(Negi et al., 2012). The levels of GPx, SOD and MDA were
significantly higher in women with PE than in healthy women,
and the increase was higher in women with severe PE (Bulgan
et al., 2005; Chamy et al., 2006). Reduced GPx levels could
be associated with increased generation of toxic lipid peroxides
contributing to the endothelial dysfunction and hypertension of
preeclampsia (Krishna and Venkataramana, 2007; Mistry et al.,
2008). Thus, these data suggest that upregulation of AAT is able
to protect vascular endothelial cells in placenta from oxidative
stress.
In addition, we find that AAT injection inactivated PE
mediated activation of PAK/STAT1/p38 signaling. Our
previous study showed that overexpression of AAT decreased
cell apoptosis and promoted proliferation via inhibiting
Rac1/PAK/p38 signaling and against oxidative stress (Feng et al.,
2015). RAC1 primarily activates p21-activated kinases (PAK) and
also interacts directly with p38 pathway to regulate proliferation,
and regulates ROS-mediated cell killing. ROS activates multiple
signaling pathway including MAPK, JAK/STAT1. Kim HS and
Lee MS suggested that STAT1 signaling amplifies the initial ROS
response through p38 MAPK activation in a positive-feedback
mechanism (Kim and Lee, 2005). Our findings suggest that
STAT1 activation by tyrosine phosphorylation but not by serine
phosphorylation and subsequent p38 activation by threonine
phosphorylation is responsible for PE. The importance of
STAT1 phosphorylation at tyrosine in apoptosis is consistent
with a previous report demonstrating the critical role of
tyrosine phosphorylation of STAT1 in apoptosis and cytotoxicity
induced by oxidative stress. Oxidative stress induces the release
of proinflammatory cytokines, such as TNF-α, IL-1β, and
COX-2, while IL-1β treatment increased p38 activity (Szabo
et al., 2015). In turn, p38 pathway has been implicated in the
posttranscriptional regulation of TNF-α and IL-1. Inhibition of
the p38 MAPK pathway significantly suppressed H/R-induced
COX-2 expression (Cindrova-Davies et al., 2007). There is
therefore the possibility of developing an autocrine feed-forward
system (Cindrova-Davies et al., 2007). Our results showed
that AAT injection exhibited an anti-oxidative stress role
by significantly reducing PE mediated-upregulation of ROS
and MDA, and increasing the levels of SOD and GPx with
increased dosage of AAT. It is possible that AAT protects
vascular endothelial cells in placenta by inhibition oxidative
stress, and subsequent decrease in release of proinflammatory
cytokines, resulting in inactivation of p38 signaling. Oxidative
stress induces the placenta to release various factors, including
inflammatory cytokines and antiangiogenic factors, resulting
in an enhanced endothelial dysfunction, which may happen
at early stage of pregnancy. However, there is no reduction
in the incidence of the disease after treating women at risk of
preeclampsia with antioxidant (Poston et al., 2006; Rumbold
et al., 2006). Considering the close relationship between oxidative
stress and p38 signaling, we infer that p38 activation may occur
at early stage of pregnancy or at more early stage to promote
oxidative stress and mediate PE, which could not reverse already
established disease pathology at late stage. Despite key roles
of STAT1/p38 in PE induced by ps/pc injection at present, we
cannot rule out the involvement of another signaling molecule
such as β-catenin signaling. Overexpression of C/EBPβ might
influence the activity of MMPs by regulating the Wnt/β-catenin
signaling pathway to affect the invasion of trophoblast cells,
which then participate in the pathogenesis of preeclampsia
(Zhuang et al., 2015). Taken together, our study suggests that
exogenous AAT improves PE via inactivating STAT1/p38
signaling.
In conclusion, our study suggests that exogenous AAT
injection increases the antioxidants and suppresses oxidative
stress, and subsequent improvement of PE through inactivation
of STAT1/p38 signaling. Thus, AAT would become a potential
strategy for PE therapy.
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